About
Combination Therapies
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
306
By Phase
PHASE1/PHASE2: 1PHASE1: 2PHASE2: 2
By Status
COMPLETED: 5
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05174039Collaborator
An Open-label Safety, Pharmacokinetic, and Efficacy Study of Miglustat for the Treatment of Subjects With Batten Ceroid Lipofuscinosis, Neuronal 3 (CLN3) Disease
PHASE1/PHASE2Completed
6 participants
Started: Mar 10, 2022 · Completed: May 30, 2024
NCT03698695Lead Sponsor
A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
PHASE1Completed
152 participants
Started: Sep 27, 2018 · Completed: Dec 20, 2019
NCT03624920Lead Sponsor
Safety and Efficacy of THN102 in Patients With Parkinson's Disease and Excessive Daytime Sleepiness
PHASE2Completed
77 participants
Started: Jul 12, 2018 · Completed: Feb 24, 2020
NCT02821715Lead Sponsor
Safety and Efficacy of THN102 on Sleepiness in Narcoleptic Patients
PHASE2Completed
51 participants
Started: Sep 30, 2016 · Completed: Feb 28, 2019
NCT03182413Lead Sponsor
Impact of THN102 on Attention, Wakefulness and Cognitive Performance During Total Sleep Deprivation
PHASE1Completed
20 participants
Started: Sep 30, 2015 · Completed: Mar 31, 2016
Locations (1)
Headquarters
Lyon, France
Map
Loading map...